| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.23 | 6e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.2 | 0.0004 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.16 | 0.0009 |